JoshuaMansourMD, MBA

PubMed

• 404 citations
  Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.
  Ujjawal H. Gandhi, Robert F. Cornell, Arjun Lakshman, Zhubin Gahvari, Elizabeth McGehee
  Leukemia. 2019-09-01
• 22 citations
  Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
  Robert F. Cornell, Parameswaran Hari, Shijie Tang, Noa Biran, Natalie S. Callander
  American Journal of Hematology. 2021-01-01
• 10 citations
  Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-c...
  Shin Yeu Ong, Stacy Pak, Matthew Mei, Yan Wang, Leslie Popplewell
  American Journal of Hematology. 2023-11-01

Journal Articles

• Allogeneic Hematopoietic Cell Transplantation for Relapsed and Refractory Philadelphia Negative B Cell ALL in the Era of Novel Salvage Therapies  
  Ibrahim Aldoss, Dongyun Yang, Monzr M. Al Malki, Matthew Mei, Sally Mokhtari, Andrew Artz, Thai Cao, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Samer Khaled, Shukaib A..., Transplantation and Cellular Therapy, 12/22/2020
• Increased bone remodeling on patients treated with a CTLA-4 inhibitor: First report of an unknown autoimmune reaction  
  Mansour, J, Rao, A, Shaheen, M, Yang, S, Ji-Hyun, L, Nordquist, H, Rixe, O, Journal of Community and Supportive Oncology, 1/1/2017
• Rare Case of Spontaneous Tumor Lysis Syndrome (TLS) in a patient with Germ Cell Tumor (GCT): Literature Review and Approach to Management  
  Mansour, J, Brill, Mathew, Gourdin, Theodore, MOJ Clinical Med Case Rep, 1/1/2017
• Prognostic value of complete remission with superior platelet counts in Acute Myeloid Leukemia  
  Mangaonkar, A, Xu, H, Mondal, A, Mansour, J, DeRemer, D, Clemmons, A, Chintalapally, R, Jillella, A, Kolhe, R, Kota, V, Journal of Community and Supportive Oncology, 1/1/2016
• Recurrent Metastatic Parotid Carcinosarcoma in an Asymptomatic Patient  
  Mansour, J, Mangaonkar, Kota, V, Journal of Investigative Medicine High Impact Case Reports, 1/1/2016
• Utility and impact of early t(15;17) identification by Fluorescence In-Situ Hybridization (FISH) in clinical decision making for patients in Acute Promyelocytic Leukem...  
  Kolhe, R, Mangaonkar, A, Mansour, J, Clemmons, A, Shaw, J, Dupont, B, Walczak, L, Mondal A, Rojiani, A, Jillela, A,Kota, V, Int J Lab Hematol, 1/1/2015
• Pneumatosis Intestinalis in an Acute Promyelocytic Leukemia (APL) patient  
  Mansour, J, Mangaonkar, A, Keen, R, Kukkadapu, T, Chintallapally, R, Kota, V, Case Reports in Hematology, 1/1/2015
• Prognostic Value of Day 30 Platelet Count After First Induction Cycle in Acute Myeloid Leukemia  
  Mangaonkar, A, Mansour, J, Clemmons, A, Kolhe, Jillella, A, Kota, V, Journal of Community and Supportive Oncology, 1/1/2015
• Significant Anti-tumor Effect of Bevacizumab in Treatment of Pineal Gland Glioblastoma Multiforme  
  Mansour, J, Fields, B, Macomson, S, Rixe, O, Targeted Oncology, 1/1/2014
• Tumor Lysis Syndrome in Retroperitoneal Sarcoma  
  Zakharia, Y, Mansour, J, Vasireddi, S, Fatakhov, E, Koch, C, Hrinczenko, B, Journal of Investigative Medicine High Impact Case Reports, 1/1/2014
• Congestive Heart Failure during induction with Anthracycline based therapy in patients with Acute Promyelocytic Leukemia may be more frequent than expected  
  Kota, V, Clemmons, A, Mansour, J, Chand, A, Simmons, J, Kolhe, R, Awan, F, Jillella, A, J Community Support Oncol, 1/1/2014
• Join now to see all

Abstracts/Posters

• Natural History of Patients with Multiple Myeloma Refractory to CD38-Targeted Monoclonal Antibody-Based Treatment
  • Gandhi¬, U, Cornell, RF, Lakshman, A, Gahvari, Z, McGehee, E, Jagosky, MH, Gupta, R, Varnado, W, Fiala, MA, Chhabra, S, Malek, E, Mansour, J, Paul, B, Barnstead, A, ..., American Society of Hematology, San Diego, CA, 12/2/2018
• Natural History of Patients with Multiple Myeloma Refractory to Elotuzumab and Outcomes of Subsequent Therapy with Anti-CD38 Monoclonal Antibodies
  • Gandhi¬, U, Cornell, RF, Lakshman, A, Gahvari, Z, McGehee, E, Jagosky, MH, Gupta, R, Varnado, W, Fiala, MA, Chhabra, S, Malek, E, Mansour, J, Paul, B, Barnstead, A, ..., American Society of Hematolgoy, San Diego, CA, 12/2/2018
• “Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Treatment.”
  • Gandhi¬, U, Cornell, RF, Lakshman, A, Gahvari, Z, McGehee, E, Jagosky, MH, Gupta, R, Varnado, W, Fiala, MA, Chhabra, S, Malek, E, Mansour, J, Paul, B, Barnstead, A, ..., ASH, San Diego, CA, 12/1/2018
• Junction Junction (AL Bradycardia), What’s your function in Multiple Myeloma?
  Rosenberg, RD, Mansour, J, Britell, A., Society of General Internal Medicine Southern Regional Meeting, New Orleans, LA, 1/11/2017
• Increased bone remodeling on patients treated with a CTLA-4 inhibitor: First report of an unknown autoimmune reaction.
  Mansour, J, Rao, A, Shaheen, M, Yang, S, Ji-Hyun, L, Nordquist, H, Rixe, O., J Clin Oncol, 1/1/2015
• Intensive Care Unit Admission in Acute Myeloid Leukemia (AML): A Single Center Experience
  Mangaonkar, A, Kota, V, Mansour, J, Mohsin, J., Graduate Research Day, Augusta, GA, 1/21/2014
• Ipililumab and Bone Resorption
  Mansour J, Mellor A, Rixe O., Graduate Research Day, Augusta, GA, 1/21/2014
• Day 30 Platelet Count as a Prognostic Marker of Survival in Acute Myeloid Leukemia
  Mangaonkar, A, Mohisn, J, Mansour, J, Ravindra Kolhe, Ashis, Mondal, Haarika, Puttagunta, Anand, Jillella, Vamsi, Kota, American Society of Hematology Annual Meeting, San Francisco, CA, 1/6/2014
• Day 30 Platelet Count as a Prognostic Marker of Survival in Acute Myeloid Leukemia.
  Mangaonkar, A, Mohsin, J, Mansour, J, Ravindra Kolhe, Ashis, Mondal, Haarika, Puttagunta, Anand, Jillella, Vamsi, Kota, Blood, 1/1/2014
• Serum Alkaline Phosphatase Level on Day 4 of G-CSF Administration Could Be a Simple Yet Practical Surrogate Marker for CD34 Mobilization and Collection.
  Zakharia, Y, Kota, V, Mansour, J, Prabhakar, R, Lan, L, Awan, F, Jillella, A., American Society of Hematology Annual Meeting, New Orleans, LA, 1/6/2013
• A Naked Man Running Down The Street
  Mangaonkar, A, Kota, V, Dave, S, Lamneck, J, Mansour, J., American College of Physicians Georgia Chapter Meeting, Savannah, GA, 1/4/2013
• Recurrent Metastatic Parotid Carcinosarcoma in an Asymptomatic Patient
  Mansour, J, Koch, C, Fatakohv, E, Zakharia, Y, American College of Physicians Georgia Chapter Meeting, Savannah, GA, 1/4/2013
• Utility of D-Dimer As a Marker for Diffrentiation Syndrome and Infections in Acute Promyelocytic Leukemia (APL)
  Mansour, J, Mangaonkar, A, Zakharia, Y, Chand, A, Jillella, A, Kota, V., Blood, 1/1/2013
• Serum Alkaline Phosphatase Level on Day 4 of G-CSF Administration Could Be a Simple Yet Practical Surrogate Marker for CD34 Mobilization and Collection.
  Zakharia, Y, Kota, V, Mansour, J, Prabhakar, R, Lan, L, Awan, F, Jillella, A., Blood, 1/1/2013
• Join now to see all

Lectures

• Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018